Sustained Codelivery of Cisplatin and Paclitaxel via an Injectable Prodrug Hydrogel for Ovarian Cancer Treatment
The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
The sustained release of both the hydrophilic drug and hydrophobic drug from one delivery system remains challenging in pharmaceutics and biomaterials science. The combination of hydrophilic cisplatin and hydrophobic paclitaxel (PTX) exhibits a clinical survival advantage compared with the individual drug therapy against various tumors such as ovarian cancer. In this study, a localized, long-term codelivery system of cisplatin and PTX was developed using an injectable and thermosensitive polymer-platinum(IV) conjugate hydrogel as the carrier. The thermosensitive Bi(mPEG-PLGA)-Pt(IV) (PtGel) conjugate was synthesized via covalently linking two mPEG-PLGA copolymers onto a Pt(IV) prodrug, and its concentrated aqueous solution exhibited a reversible sol-gel transition upon heating. Meanwhile, the core-corona micelles formed by the amphiphilic conjugates in water could serve as a reservoir for the solubilization of PTX, and thus an injectable binary drug-loaded hydrogel formulation was obtained. We also found that the introduction of PTX into the conjugate hydrogel decreased its sol-gel transition temperature and improved its gel strength. In vitro release experiments showed that both of the loaded drugs were released in a sustained manner for as long as 2.5 months, which was the longest combination delivery of these two drugs ever reported. In vitro cellular assays revealed that the dual-drug system exhibited a synergistic anticancer effect against ovarian cancer cells. Finally, using the SKOV-3 ovarian cancer xenograft mouse model, we demonstrated that a single injection of the PTX-loaded conjugate hydrogel system resulted in enhanced anticancer efficacy and significantly reduced the side effects, when compared with the multiple injections of the free drug combination.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several prior studies have reported the nanoformulations simultaneously containing PTX and cisplatin, including formulations based on polymeric micelles formed by amphiphilic block copolymers [26–28], mesoporous carbon-silica nanospheres [29], and prodrug hydrogels [30].”
Citations
Cites
Chou, T.-C., & Talalay, P. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90007-4 · Cited by 7,178
Kinetic modeling on drug release from controlled drug delivery systems.
Dash, S., Murthy, P. N., Nath, L., & Chowdhury, P. (2010) · PubMed · Cited by 2,733
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Armstrong, D. K., Bundy, B., Wenzel, L., Huang, H. Q., Baergen, R., Lele, S., Copeland, L. J., Walker, J. L., & Burger, R. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052985 · Cited by 2,625
Injectable hydrogels as unique biomedical materials
Yu, L., & Ding, J. (2008) · Chemical Society Reviews · doi:10.1039/b713009k · Cited by 1,545
Self-citationDirect Cellular Responses to Platinum-Induced DNA Damage
Jung, Y., & Lippard, S. J. (2007) · Chemical Reviews · doi:10.1021/cr068207j · Cited by 1,391
Paclitaxel and its formulations
Singla, A. K., Garg, A., & Aggarwal, D. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00986-3 · Cited by 1,100
Hydrogels for Protein Delivery
Vermonden, T., Censi, R., & Hennink, W. E. (2012) · Chemical Reviews · doi:10.1021/cr200157d · Cited by 1,091
Synergistic drug combinations tend to improve therapeutically relevant selectivity
Lehár, J., Krueger, A. S., Avery, W., Heilbut, A. M., Johansen, L. M., Price, E. R., Rickles, R. J., Short III, G. F., Staunton, J. E., Jin, X., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1549 · Cited by 938
Greco, F., & Vicent, M. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.006 · Cited by 652
Kolishetti, N., Dhar, S., Valencia, P. M., Lin, L. Q., Karnik, R., Lippard, S. J., Langer, R., & Farokhzad, O. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011368107 · Cited by 565
Research works printed but not linked: 2
- Hayashi T., 2006, Gan to Kagaku Ryoho, 33, 1167
- Dash S., 2010, Acta Pol. Pharm., 67, 217
Cited by
Hydrogel-Based Controlled Drug Delivery for Cancer Treatment: A Review
Sun, Z., Song, C., Wang, C., Hu, Y., & Wu, J. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01020 · Cited by 413
Hydrogel design strategies for drug delivery
Dreiss, C. A. (2020) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2020.02.001 · Cited by 356
“codelivery of multiple drugs (4)(5)(6)(7), simultaneous imaging and therapy (8–10), programmable and controlled release (1,11,12), the hierarchy of micro- and nano-environments accessible (hydrophobic or hydrophilic), and a plethora of additional possibilities, such as attaching ligands, combining them with nanopartic…”
BackgroundPEG-based thermosensitive and biodegradable hydrogels
Shi, J., Yu, L., & Ding, J. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.04.009 · Cited by 341
Self-citationHu, C., Zhang, F., Long, L., Kong, Q., Luo, R., & Wang, Y. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.05.010 · Cited by 290
Recent advances in regenerative biomaterials
Cao, D., & Ding, J. (2022) · Regenerative Biomaterials · doi:10.1093/rb/rbac098 · Cited by 259
“[338–340]; prodrug micelles are capable of protecting API via covalently bonding an API to amphiphilic polymers [341, 342]; PEGylation, namely, covalently grafting a PEG polymer to a drug can enhance the therapeutic properties of API by prolongation of the drug circulation in plasma [343]; even simply mixing with PEG…”
Self-citationMetallodrugs in cancer nanomedicine
Peña, Q., Wang, A., Zaremba, O., Shi, Y., Scheeren, H. W., Metselaar, J. M., Kiessling, F., Pallares, R. M., Wuttke, S., & Lammers, T. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00468a · Cited by 259
Injectable thermosensitive hydrogel-based drug delivery system for local cancer therapy
Xiao, Y., Gu, Y., Qin, L., Chen, L., Chen, X., Cui, W., Li, F., Xiang, N., & He, X. (2021) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2021.111581 · Cited by 216
Self-citationWan, X., Beaudoin, J. J., Vinod, N., Min, Y., Makita, N., Bludau, H., Jordan, R., Wang, A., Sokolsky, M., & Kabanov, A. V. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.032 · Cited by 201
“Several prior studies have reported the nanoformulations simultaneously containing PTX and cisplatin, including formulations based on polymeric micelles formed by amphiphilic block copolymers [26–28], mesoporous carbon-silica nanospheres [29], and prodrug hydrogels [30].”
BackgroundPaclitaxel-loaded pH responsive hydrogel based on self-assembled peptides for tumor targeting
Raza, F., Zhu, Y., Chen, L., You, X., Zhang, J., Khan, A., Khan, M. W., Hasnat, M., Zafar, H., Wu, J., et al. (2019) · Biomaterials Science · doi:10.1039/c9bm00139e · Cited by 193
Recent advances in supramolecular hydrogels for biomedical applications
Lim, J. Y. C., Lin, Q., Xue, K., & Loh, X. J. (2019) · Materials Today Advances · doi:10.1016/j.mtadv.2019.100021 · Cited by 182
Poustchi, F., Amani, H., Ahmadian, Z., Niknezhad, S. V., Mehrabi, S., Santos, H. A., & Shahbazi, M. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202001571 · Cited by 169
Nanoarchitecture-Integrated Hydrogel Systems toward Therapeutic Applications
Zhu, H., Zheng, J., Oh, X. Y., Chan, C. Y., Low, B. Q. L., Tor, J. Q., Jiang, W., Ye, E., Loh, X. J., & Li, Z. (2023) · ACS Nano · doi:10.1021/acsnano.2c12448 · Cited by 151
Cao, D., Zhang, X., Akabar, M., Luo, Y., Wu, H., Ke, X., & Ci, T. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1548470 · Cited by 141
“Severe side effects due to the high concentration of drug will be reduced since the drug is administered topically instead of intravenous administration [10].”
BackgroundFarooq, M. A., Aquib, M., Farooq, A., Khan, D. H., Maviah, M. B. J., Filli, M. S., Kesse, S., Boakye‐Yiadom, K. O., Mavlyanova, R., Parveen, A., et al. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1604535 · Cited by 145
“The extended release of dual drug was observed for about two and a half months, with improved anti-cancerous effect against the SKOV-3 ovarian cancer xenograft mouse models [132].”
BackgroundPeptide-/Drug-Directed Self-Assembly of Hybrid Polyurethane Hydrogels for Wound Healing
Zhang, F., Hu, C., Kong, Q., Luo, R., & Wang, Y. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b13708 · Cited by 130
Injectable Hydrogels for Cancer Therapy over the Last Decade
Cirillo, G., Spizzirri, U. G., Curcio, M., Nicoletta, F. P., & Iemma, F. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11090486 · Cited by 120
“[93] MPEG-PLGA (Physical – T) MPEG-PLGA - - - - - PTX (4.”
BackgroundWang, Y., Yang, X., Chen, X., Wang, X., Wang, Y., Wang, H., Chen, Z., Cao, D., Yu, L., & Ding, J. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202206554 · Cited by 126
Self-citationShi, K., Xue, B., Jia, Y., Yuan, L., Han, R., Yang, F., Peng, J., & Qian, Z. (2019) · Nano Research · doi:10.1007/s12274-019-2342-7 · Cited by 113
Karavasili, C., Αndreadis, D. A., Katsamenis, O. L., Panteris, E., Anastasiadou, P. A., Kakazanis, Z., Zoumpourlis, V., Markopoulou, C. K., Koutsopoulos, S., Vizirianakis, I. S., et al. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01221 · Cited by 107
Stimuli-responsive hydrogels for intratumoral drug delivery
Marques, A. C., Costa, P. J., Velho, S., & Amaral, M. H. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.04.012 · Cited by 112
Hydrogels as Emerging Materials for Translational Biomedicine
Xue, K., Wang, X., Yong, P. W., Young, D. J., Wu, Y., Li, Z., & Loh, X. J. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800088 · Cited by 111
Tao, J., Zhang, Y., Shen, A., Yang, Y., Diao, L., Wang, L., Cai, D., & Hu, Y. J. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s247088 · Cited by 105
Double-Network Polyurethane-Gelatin Hydrogel with Tunable Modulus for High-Resolution 3D Bioprinting
Hsieh, C., & Hsu, S. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b10784 · Cited by 104
Smart hydrogel: A new platform for cancer therapy
Li, G., Fu, Z.-M., Li, H., Wei, R., Guo, J., Wang, H., & Qi, J. (2025) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2025.103470 · Cited by 109
Yu, S., He, C., & Chen, X. (2018) · Macromolecular Bioscience · doi:10.1002/mabi.201800240 · Cited by 95
Self-citationIonic liquid-based gels for biomedical applications
Gao, Y., Zhang, W., Li, L., Wang, Z., Shu, Y., & Wang, J. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.139248 · Cited by 91
Chen, Y., Shi, J., Zhang, Y., Miao, J., Zhao, Z., Jin, X., Liu, L., Yu, L., Shen, C., & Ding, J. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb02523e · Cited by 84
Self-citationInjectable Thermoresponsive Hydrogels for Cancer Therapy: Challenges and Prospects
Tanga, S., Aucamp, M. E., & Ramburrun, P. (2023) · Gels · doi:10.3390/gels9050418 · Cited by 87
“Their degradation time can also be very long [107], thus impeding the transport of drug molecules to the tumour via an erosion‐based release mechanism.”
BackgroundAdvances in the antimicrobial treatment of osteomyelitis
Zhong, C., Wu, Y., Lin, H., & Liu, R. (2022) · Composites Part B Engineering · doi:10.1016/j.compositesb.2022.110428 · Cited by 91
Stimuli‐Responsive Prodrug Chemistries for Drug Delivery
Taresco, V., Alexander, C., Singh, N., & Pearce, A. K. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800030 · Cited by 84
Yang, X., Chen, X., Wang, Y., Xu, G., Yu, L., & Ding, J. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.125320 · Cited by 76
Self-citationRecent Studies and Progress in the Intratumoral Administration of Nano-Sized Drug Delivery Systems
Yun, W. S., Kim, J., Lim, D.-K., Kim, D.-H., Jeon, S. I., & Kim, K. (2023) · Nanomaterials · doi:10.3390/nano13152225 · Cited by 76
“proposed a micelle–hydrogel transition system that enabled the sustained release of both hydrophilic and hydrophobic drugs (Figure 1A,B) [104].”
BackgroundIonic liquids in polymer technology
Salas, R., Villa, R., Velasco, F., Cirujano, F. G., Nieto, S., Martín, N., García‐Verdugo, E., Dupont, J., & Lozano, P. (2024) · Green Chemistry · doi:10.1039/d4gc05445h · Cited by 98
Zhuang, Y., Yang, X., Li, Y., Chen, Y., Peng, X., Yu, L., & Ding, J. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b10346 · Cited by 69
Self-citationZou, L., Liu, X., Li, J., Li, W., Zhang, L., Fu, C., Zhang, J., & Gu, Z. (2021) · Theranostics · doi:10.7150/thno.42260 · Cited by 70
Cui, X., Sun, Y., Shen, M., Song, K., Yin, X., Di, W. J., & Duan, Y. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b19183 · Cited by 66
pH-Responsive Biocompatible Nanocomposite Hydrogels for Therapeutic Drug Delivery
Kouser, R., Vashist, A., Zafaryab, M., Rizvi, M. M. A., & Ahmad, S. (2018) · ACS Applied Bio Materials · doi:10.1021/acsabm.8b00260 · Cited by 66
Drug-loaded implantable surgical cavity-adaptive hydrogels for prevention of local tumor recurrence
Zhuang, B. A., Chen, T., Xiao, Z., & Jin, Y. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119048 · Cited by 71
Implantable and Injectable Biomaterial Scaffolds for Cancer Immunotherapy
Li, J., Luo, Y., Li, B., Xia, Y., Wang, H., & Fu, C. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.612950 · Cited by 67
The recent advancement in the PLGA-based thermo-sensitive hydrogel for smart drug delivery
Rahmani, F., Atabaki, R., Behrouzi, S., Mohamadpour, F., & Kamali, H. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122484 · Cited by 74
Poly(vinyl alcohol) and Functionalized Ionic Liquid-Based Smart Hydrogels for Doxorubicin Release
Kuddushi, M., Ray, D., Aswal, V. K., Hoskins, C., & Malek, N. I. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00393 · Cited by 64
Thermosensitive polymer hydrogel as a physical shield on colonic mucosa for colitis treatment
Guo, Z., Bai, Y., Zhang, Z., Mei, H., Li, J., Pu, Y., Zhao, N., Gao, W., Wu, F., He, B., et al. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb00499a · Cited by 64
Delivery technologies for women’s health applications
Swingle, K. L., Ricciardi, A. S., Peranteau, W. H., & Mitchell, M. J. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00040-w · Cited by 69
Patra, P., Upadhyay, T. K., Alshammari, N. I., Saeed, M., & Kesari, K. K. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00984 · Cited by 70
Wu, H., Luo, Y., Xu, D., Ke, X., & Ci, T. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.08.068 · Cited by 59
Li, L., Wang, C., Huang, Q., Xiao, J., Zhang, Q., & Cheng, Y. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb00091c · Cited by 61
Liu, D., Wu, Q., Zhu, Y., Liu, Y., Xie, X., Li, S., Lin, H., Chen, W., & Zhu, F. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1609623 · Cited by 56
“It might be attributed to the MET, which increases the antiangiogenic thrombospondin-1 (TSP-1) and decreases the level of VEGF receptor Flk-1 as well (Tan et al., 2009; Joe et al., 2015).”
BackgroundInfluentialPolymeric Nanoparticle Delivery of Combination Therapy with Synergistic Effects in Ovarian Cancer
Levit, S. L., & Tang, C. (2021) · Nanomaterials · doi:10.3390/nano11041048 · Cited by 61
“PLGA-PEG cisplatin/ paclitaxel SKOV-3 The co-loaded formulation was significantly more potent than prodrug stabilizer (3600-fold decrease in IC50) [74]”
BackgroundFlexible polymeric patch based nanotherapeutics against non-cancer therapy
Zhu, H., Mah, J. J. Q., Wang, C. G., Chan, C. Y., Zhu, Q., Ye, E., Li, Z., & Loh, X. J. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.03.034 · Cited by 73
Xu, W.-K., Tang, J.-Y., Zhang, Y., Cai, C.-Y., Chen, X., Cui, S., Liu, P., Yu, L., Cai, K., & Ding, J. (2019) · Chinese Journal of Polymer Science · doi:10.1007/s10118-019-2212-5 · Cited by 56
Self-citationJian-yong, M., Wang, B., Shao, H., Zhang, S., Chen, X., Li, F., & Liang, W. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2070299 · Cited by 56
“…polymers (e.g. chitosan (CTS) (Jamal et al., 2018), hyaluronic acid (HA) (Cho et al., 2015), alginate (ALG) (Shih et al., 2018), poly-esters (Shen et al., 2017), and polyphosphazene (PPZ) (Society, 2018)) which are rapidly depleted by cells and remodeled in the body after administration…”
Self-citationPhotoresponsive metallopolymer nanoparticles for cancer theranostics
He, M., Chen, F., Shao, D., Weis, P., Wei, Z., & Sun, W. C. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120915 · Cited by 51
A Carrier-Free Nanostructure Based on Platinum(IV) Prodrug Enhances Cellular Uptake and Cytotoxicity
Tan, J., Li, C., Wang, Q., Li, S., Chen, S., Zhang, J., Wang, P. C., Ren, L., & Liang, X. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00070 · Cited by 48
Li, X., Zou, B., Zhao, N., Wang, C., Du, Y., Mei, L., Wang, Y., Ma, S., Tian, X., He, J., et al. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b10668 · Cited by 47
Cheng, Y., Zhang, Y., Deng, W., & Hu, J. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.110744 · Cited by 47
Liu, H., Prachyathipsakul, T., Koyasseril-Yehiya, T. M., Le, S. P., & Thayumanavan, S. (2022) · Materials Horizons · doi:10.1039/d1mh01091c · Cited by 49
Versatile Applications of Metallopolymers
Götz, S., Zechel, S., Hager, M. D., Newkome, G. R., & Schubert, U. S. (2021) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2021.101428 · Cited by 51
Nanoparticle-Based Combination Therapy for Ovarian Cancer
Wu, Y., Yang, Y., Lv, X., Gao, M., Gong, X., Yao, Q., & Liu, Y. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s394383 · Cited by 53
“42 The dual-drug system exhibited a synergistic anticancer effect against SKOV3 ovarian cancer cells and excellent in vivo anticancer efficacy with significantly reduced side effects in SKOV3 ovarian cancer xenograft mouse model.”
Luan, J., Zhang, Z., Shen, W., Chen, Y., Yang, X., Chen, X., Yu, L., Sun, J., & Ding, J. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b13548 · Cited by 44
Self-citationKouser, R., Vashist, A., Zafaryab, M., Rizvi, M. M. A., & Ahmad, S. (2018) · ACS Omega · doi:10.1021/acsomega.8b01691 · Cited by 48
Jang, H., Zhi, K., Wang, J., Zhao, H., Li, B., & Yang, X. H. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.01.094 · Cited by 44
Nanomedicine and versatile therapies for cancer treatment
Shukla, A., & Maiti, P. (2022) · MedComm · doi:10.1002/mco2.163 · Cited by 51
Emerging platinum(IV) prodrug nanotherapeutics: A new epoch for platinum-based cancer therapy
Zheng, S., Li, G., Shi, J., Liu, X., Li, M., He, Z., Tian, C., & Kamei, K. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.08.035 · Cited by 46
Wang, D., Yang, X., Liu, Q., Yu, L., & Ding, J. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb01949e · Cited by 45
Self-citationYang, H., Lei, K., Zhou, F., Yang, X., An, Q., Zhu, W. P., Yu, L., & Ding, J. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.04.075 · Cited by 43
Self-citationHe, D. N., & Li, H. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202004709 · Cited by 44
ROS‐Sensitive Degradable PEG–PCL–PEG Micellar Thermogel
Lee, H. J., & Jeong, B. (2019) · Small · doi:10.1002/smll.201903045 · Cited by 43
Li, A., Si, Y., Wang, X., Jia, X., Guo, X., & Xu, Y. (2019) · ACS Applied Nano Materials · doi:10.1021/acsanm.8b01786 · Cited by 40
Thi, T. T. H., Sinh, L. H., Huỳnh, Đ. P., Nguyen, D. H., & Huynh, C. T. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00019 · Cited by 42
Hao, W., Zheng, Z., Zhu, L., Pang, L., Ma, J., Zhu, S., Du, L., & Jin, Y. (2020) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2020.06.002 · Cited by 36
Improved paclitaxel delivery with PEG-b-PLA/zein nanoparticles prepared via flash nanoprecipitation
Ye, W., Zhu, F., Cai, Y., Wang, L., Zhang, G., Zhao, G., Chu, X., Shuai, Q., & Yan, Y. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.09.021 · Cited by 37
Postoperative cancer treatments: In-situ delivery system designed on demand
Zhang, Y., & Jiang, C. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.12.038 · Cited by 37
Kong, Y., Dai, Y., Qi, D., Du, W., Ni, H., Zhang, F., Zhao, H., Shen, Q., Li, M., & Fan, Q. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c00864 · Cited by 37
Kuddushi, M., Pandey, D. K., Singh, D. K., Mata, J. P., & Malek, N. I. (2021) · Materials Advances · doi:10.1039/d1ma00835h · Cited by 37
Jiang, G., Wang, X., Zhou, Y., Zou, C., Wang, L., Wang, W., Zhang, D., Xu, H., Li, J., Li, F., et al. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s298252 · Cited by 35
Wang, T., Ding, J., Chen, Z., Zhang, Z., Rong, Y., Li, G., He, C., & Chen, X. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c18306 · Cited by 34
Self-citationRedox/pH-responsive hollow manganese dioxide nanoparticles for thyroid cancer treatment
Liu, J.-R., Guo, C., Li, C., Jia, Q., Xie, Z., Wang, Z., Tian, H., Li, Z., & Hao, L. (2023) · Frontiers in Chemistry · doi:10.3389/fchem.2023.1249472 · Cited by 34
“CDDP refers to a powerful anticancer drug that has been extensively employed to treat ovarian cancer (Cheng et al., 2011; Shen et al., 2017), thyroid cancer (Gao et al.”
BackgroundYang, X., Wang, Y., Mao, T., Wang, Y., Liu, R., Yu, L., & Ding, J. (2021) · Biomaterials Science · doi:10.1039/d1bm01280k · Cited by 34
Self-citationTao, N., Liu, Y., Wu, Y., Li, X., Li, J., Sun, X., Chen, S., & Liu, Y. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00465 · Cited by 32
Targeted drug conjugate systems for ovarian cancer chemotherapy
Ogundipe, O. D., Olajubutu, O., & Adesina, S. K. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115151 · Cited by 48
Chang, H., Wei, H., Qi, Y., Ding, S., Li, H., & Si, S. (2025) · Cell Biology and Toxicology · doi:10.1007/s10565-025-10064-0 · Cited by 41
“For instance, iron oxide nanoparticles was integrated into hydrogels to create theranostic platforms that allow for magnetic resonance imaging (MRI) of tumors while delivering chemotherapeutic agents (Han et al. 2024; Yoon, et al. 2021; Shen et al. 2017).”
Andrgie, A. T., Mekuria, S. L., Addisu, K. D., Hailemeskel, B. Z., Hsu, W., Tsai, H., & Lai, J. (2019) · Macromolecular Bioscience · doi:10.1002/mabi.201800409 · Cited by 29
Coarse-Grained Molecular Dynamics Simulations of Paclitaxel-Loaded Polymeric Micelles
Duran, T., Costa, A., Gupta, A., Xu, X., Zhang, H., Burgess, D. J., & Chaudhuri, B. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00800 · Cited by 27
Lee, K. K., Go, K., Lee, E., Kim, H., Kim, S., Kim, J., Chae, M. S., & Jeong, J.-O. (2025) · Gels · doi:10.3390/gels11060426 · Cited by 35
Yang, B., Wei, Z., Chen, X., Wei, K., & Bian, L. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb02021c · Cited by 23
Self-citationHydrogel-based drug delivery systems for enhanced tumor therapy
Tian, S., Yang, S., & Liu, Y. (2026) · RSC Advances · doi:10.1039/d5ra08269b · Cited by 28
Braet, H., Fransen, P.-P. K. H., Mariën, R., Lollo, G., Ceelen, W. P., Vervaet, C., Balcaen, L. I. L., Vanhaecke, F., Vanhove, C., van der Vegte, S., et al. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c11274 · Cited by 24
Recent advances in hydrogel-based drug delivery systems for enhanced cancer therapy: A review
Davodabadi, F., Sargazi, S., & Baino, F. (2025) · Materials Today Communications · doi:10.1016/j.mtcomm.2025.113615 · Cited by 41
He, M., Wang, R., Wan, P., Wang, H., Cheng, Y., Miao, P., Wei, Z., Leng, X., Li, Y., Du, J., et al. (2022) · Biomacromolecules · doi:10.1021/acs.biomac.1c01651 · Cited by 21
Cisplatin-Conjugated Polyurethane Capsule for Dual Drug Delivery to a Cancer Cell
Barman, R., Bej, R., Dey, P., & Ghosh, S. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c22146 · Cited by 21
Nanoplatforms: The future of oral cancer treatment
Senevirathna, K., Jayawickrama, S. M., Jayasinghe, Y. A., Prabani, K. I. P., Akshala, K., Pradeep, R., Damayanthi, H. D. W. T., Hettiarachchi, P. V. K. S., Dorji, T., Lucero‐Prisno, D. E., et al. (2023) · Health Science Reports · doi:10.1002/hsr2.1471 · Cited by 23
Lajous, H., Riva, R., Lelièvre, B., Tétaud, C., Avril, S., Hindré, F., Boury, F., Jérôme, C., Lecomte, P., & Garcion, E. (2018) · Biomaterials Science · doi:10.1039/c8bm00346g · Cited by 23
Nanocarriers containing platinum compounds for combination chemotherapy
Fang, G., Zhang, A., Zhu, L., Wang, Q., Sun, F., & Tang, B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1050928 · Cited by 24
“, 2014), Pt(IV)-conjugated copolymer (mPEG-PLGA) micelles (Shen et al., 2017), Folic acid-modified PEG-PLGA nanoparticles and nanostructured lipid carriers (He et al.”
BackgroundCisplatin and paclitaxel co-delivery nanosystem for ovarian cancer chemotherapy
Wang, Q., Wu, C., Li, X., Yang, D., & Shi, L. (2021) · Regenerative Biomaterials · doi:10.1093/rb/rbab015 · Cited by 19
“This is because CP has no functional groups that can be chemically conjugated with polymer [18].”
BackgroundLv, Q., Yu, S., Quan, F., He, C., & Chen, X. (2020) · Advanced Therapeutics · doi:10.1002/adtp.201900165 · Cited by 18
Self-citationFeng, W., Zhao, W., Chen, Z., Zhang, C., Ge, J., Zheng, X., Ren, H., & Bo, S. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00504 · Cited by 18
Pouso, M. R., Melo, B. L., Gonçalves, J. J., Louro, R. O., Mendonça, A., Correia, I. J., & de Melo‐Diogo, D. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125640 · Cited by 17
Shamsabadipour, A., Pourmadadi, M., Davodabadi, F., Rahdar, A., & Ferreira, L. F. R. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104681 · Cited by 19
Platinum Drug‐Incorporating Polymeric Nanosystems for Precise Cancer Therapy
Liu, W., Li, X., Wang, T., Xiong, F., Sun, C., Yao, X., & Huang, W. (2023) · Small · doi:10.1002/smll.202208241 · Cited by 18
Injectable hydrogel systems for local cancer therapy
Kim, S., Kim, D., Karmakar, M., & Cho, H. (2024) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-024-00678-7 · Cited by 18
“Shen et al. (2017) synthesized an mPEG-PLGA-conjugated Pt(IV) prodrug (i.e., cisplatin) via covalent bonds, and micelles were formed by self-assembly.”
Metadata
- Authors
- Shen, W., Chen, X., Luan, J., Wang, D., Yu, L., & Ding, J.
- Affiliations
- Fudan University (CN)
- Corresponding author
- Yu, Lin
- Venue
- ACS Applied Materials & Interfaces
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-11-13
- Volume
- 9
- Issue
- 46
- Pages
- 40031-40046
- ISSN
- 1944-8244 (ISSN-L)
- 1944-8252
- OpenAlex
- W2770498164
- Cited by
- 138
- References
- 65
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 8 · 2023: 17 · 2022: 15 · 2021: 20 · 2020: 17 · 2019: 21 · 2018: 16
- FWCI
- 5.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- ACS Applied Materials & Interfaces (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Science and Technology of the People's Republic of China (2016YFC1100300)
- National Natural Science Foundation of China (21474019, 51273217)
- Science and Technology Developing Foundation of Shanghai (15JC1490300)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- cisplatin, paclitaxel, ovarian cancer, co-delivery, injectable hydrogel, thermosensitive hydrogel, platinum(IV) prodrugs, sol-gel transition, sustained drug release, combination chemotherapy, synergistic antitumor effect, SKOV3 xenograft
- MeSH terms
- Animals, Cisplatin, Drug Carriers, Female, Micelles, Ovarian Neoplasms, Polyethylene Glycols, Prodrugs, Drug Delivery Systems, Paclitaxel, Hydrogels, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.